About this episode
Oct 19
Episode 228: Tickborne Illnesses
Tickborne illnesses in the ED: attachment time, the rash, the smear, prophylaxis, & treatment. Hosts: Samantha Nakos, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Tickborne_Illnesses_1_.mp3 Download Leave a Comment Tags: Babesiosis, Ehrlichios ... Show More
7m 55s
Sep 24
Episode 227: Diarrhea
Acute diarrhea in the ED: stool testing, treatment, and a spotlight on Cyclospora. Hosts: Neya Vishwanath, MD Brian Gilberti, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Diarrhea.mp3 Download Leave a Comment Tags: Gastrointestinal, Gastrointestinal Diseases Pod ... Show More
14m 58s
Aug 11
Episode 226: Superwarfarin Toxicity
Superwarfarin toxicity: recognition, reversal, and prolonged vitamin K therapy. Hosts: Mac Josh Reandelar, DO Avir Mitra, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Superwarfarin_Toxicity.mp3 Download Leave a Comment Tags: Toxicology Show Notes Toxicology & Pa ... Show More
13m 54s
Feb 2021
Diabetic Ketoacidosis; Roadside to Resus
<p>Welcome back to the podcast and our next Roadside to Resus episode, this time we're taking a look at Diabetic Ketoacidosis, DKA.</p> <p>In this episode we'll be getting our heads around the pathophysiology that underpins DKA, consider the clinical picture and severity of patie ... Show More
58m 41s
Dec 2011
Diabetic Ketoacidosis (DKA)
This is a topic episode on Diabetic Ketoacidosis (DKA). We'll discuss the diagnosis and treatment of this complex disease process and how to avoid pitfalls that can harm the patient. There will also be tons of clinical pearls including treatment of DKA's cousin Hyperglycemic Hype ... Show More
21m 21s
Sep 2018
IBCC Episode 1 - DKA
In this episode, we cover the anatomy of a DKA resuscitation. Check the post out for some juicy pearls. As always, the pitfalls: Missing an underlying cause of DKA, especially sepsis. The primary cause of death among patients admitted with DKA isn't the DKA itself, but rather as ... Show More
22m 32s
Dec 2018
Diabetic Ketoacidosis
This podcast presents an approach to management of diabetic ketoacidosis in children. In this episode, listeners will learn signs and symptoms, diagnostic criteria, and the differential diagnosis for triggers of diabetic ketoacidosis. This podcast was created by Dr. Carly Rumley ... Show More
26m 18s
Nov 2022
Deep Dive MW R4
Diabetic Ketoacidosis – hyperglycemia, ketosis, and anion gap metabolic acidosis Don’t forget about euglycemic DKA (especially in setting of SGLT2 inhibitor) or mimics such as alcoholic ketoacidosis Treatment of the ketoacidosis Insulin (usually a drip or bolus + drip) – only onc ... Show More
24m 57s
Nov 2023
Pediatric DKA and HHS
In this episode, Sam Ashoo, MD, and TR Eckler, MD, discuss the November 2023 Pediatric Emergency Medicine Practice article, Pediatric Diabetes: Management of Acute Complications in the Emergency Department and some of the highlights from the other EB Medicine articles published i ... Show More
1h 6m
Aug 2024
DKA Management: Balanced Electrolyte Solutions vs. Saline
In this episode of the Saving Lives Podcast, Eddy Joe delves into the latest research comparing balanced electrolyte solutions to 0.9% saline for treating diabetic ketoacidosis (DKA). Discover how BES could potentially revolutionize DKA management by speeding up recovery and redu ... Show More
9m 7s
Dec 2019
87 Pediatric DKA
Join Zac Hodges, Chris Watson, and Dan McCollum as they discuss the management of pediatric diabetic ketoacidosis, or DKA. What are key findings on the history and physical exam that point to DKA? What is the initial management of these patients? How is the management similar ... Show More
23m 11s
Feb 2024
Glycemic Control in the Critically Ill: Part I
Glycemic Control in the Critically Ill: Part I Special Guest: Traci Grucz, PharmD, BCCCP @tmgrucz 04:50 – ICU hyperglycemia mechanism 09:52 – Background/landmark research 27:00 – Current recommendations 30:25 – Hyperglycemia and hypoglycemia tips/tricks 46:30 – Treatment consider ... Show More
1h 1m
Iron overdose in the ED: five stages, elemental iron math, decontamination, and deferoxamine.
Hosts:
Brian Chastain, MD
Brian Gilberti, MD
Download
Leave a Comment
Tags: Toxicology
Podcast Video
Show Notes
Core EM Modular CME Course
Maximize your commute with the new Core EM Modular CME Course, featuring the most essential content distilled from our top-rated podcast episodes. This course offers 12 audio-based modules packed with pearls! Information and link below. Course Highlights:
- Credit: 12.5 AMA PRA Category 1 Credits™
- Curriculum: Comprehensive coverage of Core Emergency Medicine, with 12 modules spanning from Critical Care to Pediatrics.
- Cost:
- Free for NYU Learners
- $250 for Non-NYU Learners
Iron Poisoning Stages at a Glance
| Stage |
Timing |
What’s happening |
| 1 · GI |
30 min–6 h |
Direct corrosive GI injury; abd pain, vomiting |
| 2 · Latent |
6–24 h |
GI sx improve; iron redistributing into tissues |
| 3 · Shock / acidosis |
6–72 h |
Profound metabolic acidosis → shock, MSOF |
| 4 · Hepatotoxicity |
12–96 h |
Hepatotoxicity → fulminant liver failure |
| 5 · GI scarring |
2–8 wks |
Gastric outlet obstruction, GI tract scarring |
The Case
- 31M w/ hx depression, anxiety; found minimally responsive at home by family
- EMS: HR 67, SpO2 96% on 2 L NC, BP 46/21; withdraws to pain, not opening eyes → 2 L IVF + push-dose epi en route
- ED: BP ↑ to 90/61, other VS unchanged; dried vomit on lips/shirt; breathing comfortably, protecting airway
- POC VBG: pH 7.24, pCO2 33, pO2 25, HCO3 14, lactate 2.5
- ECG: NSR, otherwise unremarkable → get an ECG in any possible toxic ingestion
- Additional 30 mL/kg bolus + norepi gtt
- Family arrives → bottle of iron pills under the pt’s bed
Pathophysiology
- Free iron = multisystem oxidative injury
- Primary mechanism: free radical generation + lipid peroxidation → damages cellular and mitochondrial membranes throughout the body
- Profound metabolic acidosis via 2 routes: uncoupled oxidative phosphorylation → anaerobic metabolism → lactate; Fe³⁺ reacts w/ water → releases 3 H⁺ → excess acid
- Direct mucosal necrosis in the gut (corrosive injury)
- Negative inotrope on the myocardium → hypotension, cardiogenic shock in large ingestions
Clinical Stages
- Classic progression after large ingestions; stages overlap and pts can present anywhere along the timeline
- Stage 1, GI (30 min–6 h): direct GI tract injury; abd pain, vomiting. Persistent vomiting = very sensitive indicator of a serious ingestion
- Stage 2, latent (6–24 h): GI sx improve, but iron is redistributing into the tissues → ongoing damage
- The latent-phase trap: pts look like they’re turning the corner right before they crump. Contrast: pts never symptomatic >6 h after ingestion are unlikely to develop toxicity (AAPCC 2005); GI sx that improve ≠ never symptomatic
- Stage 3, shock (6–72 h): tissue iron → profound acidosis → shock, MSOF
- Stage 4, hepatotoxicity (12–96 h): hepatotoxicity → fulminant liver failure
- Stage 5, GI scarring (2–8 wks): gastric outlet obstruction, GI tract scarring from the initial corrosive injury
Diagnosis / Workup
Imaging
- Emergent plain-film abd XR in any suspected iron ingestion → intact adult iron tabs are radiopaque
- Confirms pills still in the stomach/GI tract → helps decide on WBI
- Negative XR ≠ no ingestion: chewables, liquid formulations and already-dissolved tabs often don’t show up
Serum Iron
- Draw 4–6 h post-ingestion for regular formulations, ~8 h for extended release
- Often hard to interpret → time of ingestion and formulation frequently unknown
- >500 mcg/dL → serious systemic toxicity
- >1,000 mcg/dL → very significant mortality
Elemental Iron Math
- Toxicity tracks the elemental iron dose, not the mass of the pill
| Salt |
Elemental Fe |
Per 325 mg tab |
| Ferrous sulfate |
~20% |
~65 mg |
| Ferrous fumarate |
~33% |
106 mg |
| Ferrous gluconate |
~12% |
~36–38 mg |
- <20 mg/kg elemental Fe → usually asymptomatic
- 20–60 mg/kg → GI sx likely; systemic toxicity possible, esp. at the upper end
- >60 mg/kg → threshold for serious toxicity, possible death
- AAPCC out-of-hospital guideline: refer to an ED for ≥40 mg/kg elemental Fe (adult ferrous salt formulations) or severe/persistent sx; any self-harm ingestion → ED regardless of amount (Manoguerra 2005)
- AAPCC: children’s chewable vitamins w/ iron, and unintentional carbonyl iron or polysaccharide-iron complex ingestions → home obs w/ f/u
Management
Decontamination
- Activated charcoal: no role. Iron is a metal → doesn’t bind; ↑ aspiration and other complications
- Whole bowel irrigation (WBI) = main decontamination strategy, esp. w/ pills on XR → flush tablets before further GI injury and systemic absorption
- PEG-ELS (polyethylene glycol electrolyte solution) until rectal effluent is clear; large volume → often via NG tube
- PEG-ELS rates: 1.5–2 L/h adolescents/adults (as on air); peds 500 mL/h (9 mo–6 y), 1 L/h (6–12 y) (AACT/EAPCCT 1997)
- AACT/EAPCCT: consider WBI after substantial iron ingestions; contraindicated w/ bowel obstruction, perforation, ileus, hemodynamic instability or a compromised unprotected airway (Thanacoody 2015)
- Gastric lavage: generally not used unless a large pill burden remains in the stomach → aspiration, direct GI injury; ED unfamiliarity ↑ complications
- Get toxicology and your local poison center on the line early
Deferoxamine (DFO)
- Mechanism: chelator isolated from bacteria → binds iron in the blood (ferrioxamine) → renal excretion in the urine
- Indications: shock · AMS · profound metabolic acidosis · persistent GI sx (persistent vomiting) · serum iron >500 mcg/dL · predicted severe ingestion (>60 mg/kg elemental Fe) in a symptomatic pt
- Reported dose >60 mg/kg in a pt w/o sx or acidosis → discuss w/ toxicology/poison center rather than chelating on pill count alone
- Dosing: start 5 mg/kg/h IV → titrate to ~15 mg/kg/h. Some protocols go higher, up to ~30 mg/kg/h in the first 24 h.
- Watch for hypotension: DFO can worsen existing hypotension.
- FDA label: IV only for cardiovascular collapse, by slow infusion; ≤15 mg/kg/h initially; max 6 g/24 h; ARDS reported w/ excessively high IV doses; ↑ risk of Yersinia infxn.
- Urine: classic “vin rosé” (red-orange) urine = ferrioxamine being excreted → helpful but not quantitative. Its absence doesn’t exclude significant toxicity or effective chelation; don’t use urine color to guide duration.
- Stop when the pt is clinically well and the anion gap acidosis has resolved.
Pitfalls
- Waiting for a level → a level that hasn’t peaked or looks low doesn’t exclude toxicity in a sick pt
- Being reassured by GI improvement in the latent phase
- Being reassured by a negative XR (chewables, liquids, dissolved tabs)
- Dosing by tablet weight instead of elemental iron
- Giving activated charcoal
- Using urine color (or its absence) to decide when to stop DFO
Take-Home Points
- Treat the patient, not the number. Shock or profound metabolic acidosis → start DFO even if the serum iron hasn’t peaked or is lower than expected; very little harm in starting it, other than hypotension
- Calculate elemental iron. Formulations differ in elemental content → helps predict whether the dose is toxic
- Get an X-ray. Plain film confirms tablets and guides the decision on WBI
- Beware the latent phase. GI improvement ≠ toxicity over → often precedes cardiovascular collapse and shock as iron moves into the tissues
Links & References
Guidelines
- Manoguerra AS, et al. Iron ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2005;43(6):553–570. — DOI (AAPCC)
- Dart RC, et al. Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med. 2018;71(3):314–325.e1. — DOI
Decontamination Position Statements (AACT/EAPCCT)
- Tenenbein M. Position statement: whole bowel irrigation. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol. 1997;35(7):753–762. — DOI
- Thanacoody R, et al. Position paper update: whole bowel irrigation for gastrointestinal decontamination of overdose patients. Clin Toxicol (Phila). 2015;53(1):5–12. — DOI
- Chyka PA, et al. Position paper: single-dose activated charcoal. Clin Toxicol (Phila). 2005;43(2):61–87. — DOI
- Benson BE, et al. Position paper update: gastric lavage for gastrointestinal decontamination. Clin Toxicol (Phila). 2013;51(3):140–146. — DOI
Poison Center
- Poison Help line (US): 1-800-222-1222
Music
Read More